The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Effects of Ketogenic Diets on Cardiovascular Risk Factors: Evidence from Animal and Human Studies
Open accessAbstract
The treatment of obesity and cardiovascular diseases is one of the most difficult and important challenges nowadays. Weight loss is frequently offered as a therapy and is aimed at improving some of the components of the metabolic syndrome. Among various diets, ketogenic diets, which are very low in carbohydrates and usually high in fats and/or proteins, have gained in popularity. Results regarding the impact of such diets on cardiovascular risk factors are controversial, both in animals and humans, but some improvements notably in obesity and type 2 diabetes have been described. Unfortunately, these effects seem to be limited in time. Moreover, these diets are not totally safe and can be associated with some adverse events. Notably, in rodents, development of nonalcoholic fatty liver disease (NAFLD) and insulin resistance have been described. The aim of this review is to discuss the role of ketogenic diets on different cardiovascular risk factors in both animals and humans based on available evidence.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ng, M., Fleming, T., Robinson, M., Thomson, B., Graetz, N., Margono, C., Mullany, E. C., Biryukov, S., Abbafati, C., Abera, S. F., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60460-8 · Cited by 11,952
Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications
Fabbrini, E., Sullivan, S., & Klein, S. (2010) · Hepatology · doi:10.1002/hep.23280 · Cited by 2,100
A Randomized Trial of a Low-Carbohydrate Diet for Obesity
Foster, G. D., Wyatt, H. R., Hill, J. O., McGuckin, B. G., Brill, C., Mohammed, B. S., Szapary, P. O., Rader, D. J., Edman, J. S., & Klein, S. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022207 · Cited by 1,794 · cited 8×
“found a significant improvement in insulin sensitivity at 6 months, but not at 1 year [33].”
BackgroundResultInfluentialBadman, M. K., Pissios, P., Kennedy, A. R., Koukos, G., Flier, J. S., & Maratos-Flier, E. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.05.002 · Cited by 1,495 · cited 1×
“Nevertheless, the role of FGF21 in NAFLD induced by a KD has mostly been studied in rodents [26,27,48,49].”
Backgroundde Souza, R. J., Mente, A., Maroleanu, A., Cozma, A. I., Ha, V., Kishibe, T., Uleryk, E., Budylowski, P., Schünemann, H., Beyene, J., et al. (2015) · BMJ · doi:10.1136/bmj.h3978 · Cited by 1,424 · cited 2×
“evertheless, a recent syste atic revie and eta‐analysis revealed that saturated fat intake as not associated ith all‐cause and cardiovascular ortality, coronary heart disease, ische ic stroke or type 2 diabetes, but ith heterogenous evidence [87].”
BackgroundA Low-Carbohydrate as Compared with a Low-Fat Diet in Severe Obesity
Samaha, F. F., Iqbal, N., Seshadri, P., Chicano, K. L., Daily, D. A., McGrory, J., Williams, T., Williams, M., Gracely, E. J., & Stern, L. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022637 · Cited by 1,267
Xu, J., Lloyd, D. J., Hale, C., Stanislaus, S., Chen, M., Sivits, G., Vonderfecht, S., Hecht, R., Li, Y.-S., Lindberg, R. A., et al. (2009) · Diabetes · doi:10.2337/db08-0392 · Cited by 1,151
Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity
Fabbrini, E., Magkos, F., Mohammed, B. S., Pietka, T., Abumrad, N. A., Patterson, B. W., Okunade, A., & Klein, S. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904944106 · Cited by 972
Feinman, R. D., Pogozelski, W. K., Astrup, A., Bernstein, R. K., Fine, E. J., Westman, E. C., Accurso, A., Frassetto, L., Gower, B. A., McFarlane, S. I., et al. (2015) · Nutrition · doi:10.1016/j.nut.2014.06.011 · Cited by 912
Stern, L., Iqbal, N., Seshadri, P., Chicano, K. L., Daily, D. A., McGrory, J., Williams, M., Gracely, E. J., & Samaha, F. F. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-10-200405180-00007 · Cited by 831 · cited 1×
“Nevertheless, several studies showed an increase in LDL cholesterol levels [82,83,85,86], but not significantly in the trial by Westman et al.”
BackgroundMcKeown, N. M., Meigs, J. B., Liu, S., Saltzman, E., Wilson, P. W. F., & Jacques, P. F. (2004) · Diabetes Care · doi:10.2337/diacare.27.2.538 · Cited by 786 · cited 1×
“In the literature, diets rich in carbohydrates, and notably rich in refined sugars and fructose, are associated with the metabolic syndrome [8,9].”
BackgroundBueno, N. B., de Melo, I. S. V., de Oliveira, S. L., & da Rocha Ataide, T. (2013) · British Journal of Nutrition · doi:10.1017/s0007114513000548 · Cited by 778 · cited 1×
“It is interesting to note that in the studies (only 4) with 24 months of follow-up, only the change in HDL cholesterol levels remained significant [91].”
BackgroundFGF21 is an endocrine signal of protein restriction
Laeger, T., Henagan, T. M., Albarado, D. C., Redman, L. M., Bray, G. A., Noland, R. C., Münzberg, H., Hutson, S. M., Gettys, T. W., Schwartz, M. W., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci74915 · Cited by 593 · cited 1×
“Finally, FGF21 has been shown to act as an endocrine signal of protein restriction [55].”
BackgroundBoden, G., Sargrad, K., Homko, C., Mozzoli, M., & Stein, T. P. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-6-200503150-00006 · Cited by 542
Foster, G. D., Wyatt, H. R., Hill, J. O., Makris, A. P., Rosenbaum, D. L., Brill, C., Stein, R. I., Mohammed, B. S., Miller, B., Rader, D. J., et al. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-153-3-201008030-00005 · Cited by 520
Westman, E. C., Yancy, W. S., Mavropoulos, J. C., Marquart, M., & McDuffie, J. R. (2008) · Nutrition & Metabolism · doi:10.1186/1743-7075-5-36 · Cited by 475
Johnstone, A. M., Horgan, G. W., Murison, S. D., Bremner, D. M., & Lobley, G. E. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.1.44 · Cited by 440 · cited 4×
“In other studies, total and LDL cholesterol were significantly more reduced with a high-protein medium-carbohydrate diet than with a KD [40].”
BackgroundResultInfluentialDietary fat and carbohydrates differentially alter insulin sensitivity during caloric restriction
Kirk, E., Reeds, D. N., Finck, B. N., Mayurranjan, M. S., Patterson, B. W., & Klein, S. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.01.048 · Cited by 440
Gannon, M. C., & Nuttall, F. Q. (2004) · Diabetes · doi:10.2337/diabetes.53.9.2375 · Cited by 428
A high-fat, ketogenic diet induces a unique metabolic state in mice
Kennedy, A. R., Pissios, P., Otu, H., Xue, B., Asakura, K., Furukawa, N., Marino, F. E., Liu, F.-F., Kahn, B. B., Libermann, T. A., et al. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00717.2006 · Cited by 420
Carbohydrate Restriction has a More Favorable Impact on the Metabolic Syndrome than a Low Fat Diet
Volek, J. S., Phinney, S. D., Forsythe, C. E., Quann, E. E., Wood, R. J., Puglisi, M. J., Kraemer, W. J., Bibus, D. M., Fernandez, M. L., & Feinman, R. D. (2009) · Lipids · doi:10.1007/s11745-008-3274-2 · Cited by 397
Dietary fat content modifies liver fat in overweight nondiabetic subjects
Westerbacka, J., Lammi, K., Häkkinen, A.-M., Rissanen, A., Salminen, I., Aro, A., & Yki-Järvinen, H. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1983 · Cited by 379 · cited 1×
“In humans, liver fat content was shown to be increased during an isocaloric high-fat low-carbohydrate diet [56].”
BackgroundFibroblast Growth Factor 21-Deficient Mice Demonstrate Impaired Adaptation to Ketosis
Badman, M. K., Koester, A., Flier, J. S., Kharitonenkov, A., & Maratos-Flier, E. (2009) · Endocrinology · doi:10.1210/en.2009-0532 · Cited by 362 · cited 1×
“Moreover, when the chow diet was changed for a KD, these mice not only gained weight and developed glucose intolerance, but also developed NAFLD [53].”
BackgroundComparison of low- and high-carbohydrate diets for type 2 diabetes management: a randomized trial
Tay, J., Luscombe-Marsh, N. D., Thompson, C. H., Noakes, M., Buckley, J. D., Wittert, G. A., Yancy, W. S., & Brinkworth, G. D. (2015) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.115.112581 · Cited by 341 · cited 3×
“Nevertheless, the low-carbohydrate diet led to a greater reduction in antidiabetic medications, which could overall be helpful to optimize glycemic control [43].”
BackgroundInfluentialEffect of low-calorie versus low-carbohydrate ketogenic diet in type 2 diabetes
Hussain, T. A., Mathew, T. C., Dashti, A. A., Asfar, S., Al-Zaid, N., & Dashti, H. M. (2012) · Nutrition · doi:10.1016/j.nut.2012.01.016 · Cited by 329
Browning, J. D., Baker, J. A., Rogers, T., Davis, J., Satapati, S., & Burgess, S. C. (2011) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.007674 · Cited by 328
Santos, F. L., Esteves, S. S., da Costa Pereira, A., Yancy Jr, W. S., & Nunes, J. P. L. (2012) · Obesity Reviews · doi:10.1111/j.1467-789x.2012.01021.x · Cited by 318
A ketogenic diet favorably affects serum biomarkers for cardiovascular disease in normal-weight men
Sharman, M. J., Kraemer, W. J., Love, D. M., Avery, N. G., Gómez, A. L., Scheett, T. P., & Volek, J. S. (2002) · The Journal of Nutrition · doi:10.1093/jn/132.7.1879 · Cited by 312
Volek, J. S., Fernandez, M. L., Feinman, R. D., & Phinney, S. D. (2008) · Progress in Lipid Research · doi:10.1016/j.plipres.2008.02.003 · Cited by 288
Brinkworth, G. D., Noakes, M., Buckley, J. D., Keogh, J. B., & Clifton, P. M. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.27326 · Cited by 284 · cited 3×
“In humans, KD have been associated with significant reductions in total cholesterol [75], increases in HDL cholesterol levels [33,70,75,80–83], decreases in triglycerides levels [32,33,70,75,82,83] and reductions in LDL cholesterol levels [75].”
BackgroundResultAccurso, A., Bernstein, R. K., Dahlqvist, A., Draznin, B., Feinman, R. D., Fine, E. J., Gleed, A., Jacobs, D. B., Larson, G., Lustig, R. H., et al. (2008) · Nutrition & Metabolism · doi:10.1186/1743-7075-5-9 · Cited by 263
Naude, C. E., Schoonees, A., Senekal, M., Young, T., Garner, P., & Volmink, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100652 · Cited by 252 · cited 1×
“This meta-analysis showed that strict adherence failed and declined with follow-up in most trials [92].”
MethodSaslow, L. R., Kim, S., Daubenmier, J. J., Moskowitz, J. T., Phinney, S. D., Goldman, V., Murphy, E. J., Cox, R. M., Moran, P., & Hecht, F. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091027 · Cited by 221
Gluconeogenesis and energy expenditure after a high-protein, carbohydrate-free diet
Veldhorst, M. A., Westerterp-Plantenga, M. S., & Westerterp, K. R. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.27834 · Cited by 170
Modification of Lipoproteins by Very Low-Carbohydrate Diets
Volek, J. S., Sharman, M. J., & Forsythe, C. E. (2005) · The Journal of Nutrition · doi:10.1093/jn/135.6.1339 · Cited by 159 · cited 1×
“KD have also been associated with an increase in size and volume of LDL cholesterol particles, which is considered to reduce cardiovascular risk by decreasing atherogenicity [81].”
BackgroundIqbal, N., Vetter, M. L., Moore, R. H., Chittams, J. L., Dalton‐Bakes, C. V., Dowd, M., Williams‐Smith, C., Cardillo, S., & Wadden, T. A. (2010) · Obesity · doi:10.1038/oby.2009.460 · Cited by 144
Control of blood glucose in type 2 diabetes without weight loss by modification of diet composition
Gannon, M. C., & Nuttall, F. Q. (2006) · Nutrition & Metabolism · doi:10.1186/1743-7075-3-16 · Cited by 134
Low-carbohydrate diet scores and risk of type 2 diabetes in men
de Koning, L., Fung, T. T., Liao, X., Chiuve, S. E., Rimm, E. B., Willett, W. C., Spiegelman, D., & Hu, F. B. (2011) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.004333 · Cited by 128 · cited 2×
“On the other hand, a low-carbohydrate diet high in vegetal proteins and fats was associated with a decreased risk of type 2 diabetes [77].”
BackgroundPartsalaki, Karvela, A., & Spiliotis, B. E. (2012) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2012-0131 · Cited by 107
Fgf21 Impairs Adipocyte Insulin Sensitivity in Mice Fed a Low-Carbohydrate, High-Fat Ketogenic Diet
Murata, Y., Nishio, K., Mochiyama, T., Konishi, M., Shimada, M., Ohta, H., & Itoh, N. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069330 · Cited by 54
Morris-Stiff, G., & Feldstein, A. E. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.07.003 · Cited by 26
Cited by
Association between insulin resistance and the development of cardiovascular disease
Ormazabal, V., Nair, S., Elfeky, O., Aguayo, C., Salomon, C., & Zuñiga, F. A. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0762-4 · Cited by 2,280
Gut Microbiome: Profound Implications for Diet and Disease
Hills, R., Pontefract, B., Mishcon, H., Black, C., Sutton, S., & Theberge, C. (2019) · Nutrients · doi:10.3390/nu11071613 · Cited by 1,092
Food Components and Dietary Habits: Keys for a Healthy Gut Microbiota Composition
Rinninella, E., Cintoni, M., Raoul, P., Lopetuso, L. R., Scaldaferri, F., Pulcini, G., Miggiano, G. A. D., Gasbarrini, A., & Mele, M. C. (2019) · Nutrients · doi:10.3390/nu11102393 · Cited by 673
Standard of care for lipedema in the United States
Herbst, K. L., Kahn, L. A., Iker, E., Ehrlich, C., Wright, T., McHutchison, L., Schwartz, J., Sleigh, M., Donahue, P. M., Lisson, K. H., et al. (2021) · Phlebology: The Journal of Venous Disease · doi:10.1177/02683555211015887 · Cited by 269
Freire, R. (2020) · Nutrition · doi:10.1016/j.nut.2019.07.001 · Cited by 262
Metadata
- Authors
- Kosinski, C., & Jornayvaz, F.
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2017-05-19
- Volume
- 9
- Issue
- 5
- Pages
- 517
- ISSN
- 2072-6643 (ISSN-L)
- OpenAlex
- W2615179214
- Cited by
- 210
- References
- 41
- FWCI
- 12.36
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.